Biomeme
Therapy Response Profile

Testosterone / TRT
Anabolic Response

Testosterone Replacement Therapy (TRT) coordinates profound physiological shifts in muscle mass, adipose tissue, and energy production. Transcriptomics enables clinicians to track receptor density and the balance between muscle hypertrophy and protein breakdown at the mRNA level.

Molecular Mechanism

Androgen Receptor Gene Regulation

When testosterone binds to the androgen receptor, it translocates to the nucleus to bind DNA, initiating an anabolic gene transcription program. This program promotes muscle protein synthesis via localized IGF-1 upregulation, while suppressing E3 ubiquitin ligases (MuRF1/TRIM63) that target muscle tissue for breakdown.

By tracking active transcripts, clinicians can evaluate the molecular efficacy of TRT. Measuring shifts in glucose transport (GLUT4) genes provides an index of improved insulin sensitivity and glycogen resynthesis capacity, confirming metabolic enhancement.

Key Target Genes

AR
Androgen Receptor Hormonal Signaling

Drives testosterone-mediated gene transcription in muscle, fat, and bone tissues.

IGF1
Insulin-Like Growth Factor 1 Hypertrophic Signaling

Drives local muscle protein synthesis, satellite cell activity, and muscle fiber hypertrophy.

TRIM63 (MuRF1)
Muscle Ring Finger 1 Protein Catabolism Suppression

An E3 ubiquitin ligase driving muscle breakdown; actively down-regulated by TRT to preserve muscle mass.

SLC2A4 (GLUT4)
Glucose Transporter Type 4 Glucose Metabolism

Upregulated in skeletal muscle to increase insulin-stimulated glucose uptake and glycogen storage.

Longitudinal Timeline

Expected mRNA Expression Timeline

A typical timeline showing how active gene expression signals evolve during a testosterone/TRT cycle.

Week 1–2

Anti-Catabolic Effect

Downregulation of muscle wasting genes (MuRF1/TRIM63) and upregulation of insulin transport pathways (GLUT4).

Week 4

Hypertrophic Activation

Peak expression of Androgen Receptor (AR) and localized skeletal muscle IGF-1 transcripts.

Week 8+

Anabolic Stabilization

Long-term improvements in structural recovery, metabolic adaptivity, and muscle integrity indices.

Enabling Technology

Point-of-Care Anabolic Assays

Biomeme's platform offers rapid quantitative PCR tracking for Androgen Receptor and muscle catabolic pathways. Assess structural regeneration and recovery genes in under 15 minutes, processed via CLIA-certified One Health Labs.

The Science Behind the Data

Curious how we measure this?

Learn about the foundational science of Transcriptomics and how Biomeme brings molecular profiling to the point of need.

Ready to Learn More?

Explore how Biomeme's capabilities are being deployed across the Wellness landscape.